{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:15:19Z","timestamp":1776395719790,"version":"3.51.2"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1097\/igc.0b013e31825736b2","type":"journal-article","created":{"date-parts":[[2012,6,2]],"date-time":"2012-06-02T03:41:44Z","timestamp":1338608504000},"page":"1069-1074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Intraperitoneal Chemotherapy by Ultrasound-Guided Direct Puncture in Recurrent Ovarian Cancer"],"prefix":"10.1016","volume":"22","author":[{"given":"Pierluigi","family":"Benedetti-Panici","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Perniola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Pernice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Donfrancesco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violante","family":"Di Donato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Tomao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Innocenza","family":"Palaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marialida","family":"Graziano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Basile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Bellati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e31825736b2_bb0005","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1056\/NEJM199612263352603","article-title":"Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer","volume":"335","author":"Alberts","year":"1996","journal-title":"N Engl J Med."},{"key":"10.1097\/IGC.0b013e31825736b2_bb0010","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1200\/JCO.2001.19.4.1001","volume":"19","author":"Markman","year":"2001","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31825736b2_bb0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1097\/IGC.0b013e31825736b2_bb0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/gyno.1998.4973","article-title":"A phase II trial of intraperitoneal cisplatin and etoposide as consolidation therapy in patients with stage II\u2013IV epithelial ovarian cancer following negative surgical assessment","volume":"69","author":"Barakat","year":"1998","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31825736b2_bb0025","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000287968","article-title":"Intraperitoneal paclitaxel as consolidation treatment in ovarian cancer patients: a case control study","volume":"78","author":"Benedetti Panici","year":"2010","journal-title":"Oncology."},{"key":"10.1097\/IGC.0b013e31825736b2_bb0030","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/cncr.22467","article-title":"Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer","volume":"109","author":"Marth","year":"2007","journal-title":"Cancer"},{"key":"10.1097\/IGC.0b013e31825736b2_bb0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ygyno.2009.04.001","article-title":"Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer","volume":"114","author":"Naumann","year":"2009","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31825736b2_bb0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ygyno.2007.12.004","article-title":"Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer","volume":"109","author":"Black","year":"2008","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31825736b2_bb0045","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0090-8258(03)00377-9","article-title":"First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up","volume":"90","author":"Fujiwara","year":"2003","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31825736b2_bb0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0090-8258(91)90266-8","article-title":"Intraperitoneal chemotherapy: analysis of complications with an implanted subcutaneous port and catheter system","volume":"41","author":"Davidson","year":"1991","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31825736b2_bb0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2005.11.013","article-title":"Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study","volume":"100","author":"Walker","year":"2006","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31825736b2_bb0060","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ygyno.2009.03.034","article-title":"Intraperitoneal access via direct puncture is an alternative way to deliver intraperitoneal chemotherapy in ovarian, fallopian tube and primary peritoneal cancer","volume":"114","author":"Lan","year":"2009","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31825736b2_bb0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/IGC.0b013e3181c7f670","article-title":"Factors affecting the completetion of intraperitoneal chemotherapy in women with ovarian cancer","volume":"20","author":"Robinson","year":"2010","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e31825736b2_bb0070","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1200\/JCO.2007.13.1961","article-title":"Gynecologic Oncology Group. Cost effectiveness of intraperitoneal compared with intravenous chemotherapy for women with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study","volume":"26","author":"Havrilesky","year":"2008","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31825736b2_bb0075","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ygyno.2007.10.004","article-title":"Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion rates","volume":"108","author":"Landrum","year":"2008","journal-title":"Gynecol Oncol."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24021613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24021613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1097\/IGC.0b013e31825736b2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:29:20Z","timestamp":1753223360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24021613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1048891X24021613"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e31825736b2","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intraperitoneal Chemotherapy by Ultrasound-Guided Direct Puncture in Recurrent Ovarian Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e31825736b2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2012 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}